Peter Goadsby

King’s College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Amy Gelfand

child & adolescent headache program university of california

UNITED STATES

View details

Teshamae Monteith, MD, FAHS, FAAN

Associate Professor, Clinical Neurology

University of Miami School of Medicine

UNITED STATES

View details

Anish bahra

Oxford University Hospitals NHS Foundation Trust

UNITED KINGDOM

View details

Jean Schoenen

Honorary Professor

University of Liege

BELGIUM

View details

Fernando Zelaya

King’s College London

UNITED KINGDOM

View details

Nazia Karsan

King’s College London

UNITED KINGDOM

View details

faraidoon haghdoost

The George Institute for Global Health

AUSTRALIA

View details

Patricia Pozo-Rosich

SPAIN

View details

Arne May

Universität Hamburg

GERMANY

View details

David Moreno Ajona

King’s College London

UNITED KINGDOM

View details

Eva-Maria Huessler

University Hospital Essen

GERMANY

View details

Pablo Irimia‐Sieira

SPAIN

View details

Christoph J. Schankin

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Peter Goadsby

Research Interests

Explore related searches

Contact this professor

Articles (30)

Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome

Migraine stigma and general knowledge of migraine: A cross-sectional European survey

High flow versus ultra-high flow (demand valve) oxygen delivery in cluster headache: A patient experience survey by the Organization for Understanding Cluster Headache-UK ( OUCH-UK )

International Classification of Headache Disorders-4 – Work in progress 2

Migraine: advances in treatment

Neuromodulation in trigeminal autonomic cephalalgias: 11-year experience of non-invasive vagus nerve stimulation

Cranial autonomic symptoms as a protective mechanism in patients with chronic migraine: A cross-sectional study

Ubrogepant for the treatment of migraine prodromal symptoms: an exploratory analysis from the randomized phase 3 PRODROME trial

Amylin and the amylin receptors in migraine: Is there another pathway to target?

Evaluation of premonitory spontaneous and nitroglycerin triggered symptoms among patients with cluster headache and migraine

Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study

Flexible modeling of headache frequency fluctuations in migraine with hidden Markov models

Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial

Extended Phenotyping of Migraine in Children: A Cross-Sectional Study in a Specialist Children's Headache Clinic

Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy

Pituitary cyclase‐activating polypeptide targeted treatments for the treatment of primary headache disorders

Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update

Update on cough, exertional and sex headache

Melatonin in hemicrania continua and paroxysmal hemicrania

Reply to the letter from Lansbergen et al.

Efficacy, safety and indirect comparisons of lasmiditan, rimegepant, and ubrogepant for the acute treatment of migraine: A systematic review and network meta-analysis of the literature

European Academy of Neurology guidelines on the treatment of cluster headache

Estimating treatment effects on health utility scores for patients living with migraine: a post hoc analysis of the DELIVER trial

Regional cerebral perfusion during the premonitory phase of triggered migraine: A double‐blind randomized placebo‐controlled functional imaging study using pseudo‐continuous arterial spin labeling

Social Media Listening and Digital Profiling Study of People With Headache and Migraine: Retrospective Infodemiology Study

Eptinezumab improved patient‐reported outcomes and quality of life in patients with migraine and prior preventive treatment failures

Effectiveness and safety profile of greater occipital nerve blockade in cluster headache: a systematic review

Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review

Efficacy of rimegepant for the acute treatment of migraine based on triptan treatment experience: Pooled results from three phase 3 randomized clinical trials

Comorbidity or combination – more evidence for cluster-migraine?

Collaborators (13)

Amy Gelfand

Teshamae Monteith, MD, FAHS, FAAN

Anish bahra

Jean Schoenen

Fernando Zelaya

Nazia Karsan

faraidoon haghdoost

Patricia Pozo-Rosich

Arne May

David Moreno Ajona

Eva-Maria Huessler

Pablo Irimia‐Sieira

Christoph J. Schankin

Make your next move.